About HAL Allergy
Expertise in Allergen Immunotherapy
HAL Allergy started as a small laboratory in Haarlem, the Netherlands. On request of several local general practitioners, extracts were prepared on a named patient basis to treat allergic reactions. The core business of HAL Allergy was, and still is, the treatment of allergies with allergen immunotherapies. Patients’ well-being is always our top priority.
In the 1970’s HAL Allergy grew to a mid-sized laboratory and expanded into the German market. Germany soon developed into a major export country for HAL Allergy products.
Growth to a European player
Over the years HAL Allergy grew to a European player in the field of allergen immunotherapy.
Growth to a European player made it necessary for HAL Allergy to increase capacity and we chose to relocate to the Bio Science Park in Leiden, The Netherlands. In 2009 we celebrated the opening of the new high quality GMP production facility.
In terms of technology, cutting-edge equipment was installed and the laboratory utilizes advanced equipment. This allows HAL Allergy to further improve its future growth demands and continue on its mission to improve the quality of life of our patients by providing biopharmaceutical products for causal treatment. Read more about our production facility.
Beside the development and production of allergy therapeutics, HAL Allergy started a new business in 2012. This Contract Development Manufacturing Organization (CDMO), named HALIX, is engaged in the production of biotechnological products and licensed for clinical and commercial GMP contract manufacturing of biopharmaceuticals.